Rabies 3 Year Vaccine

Verify with FDA CVM →

19 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
1
Deaths Reported
530.0%
Death Rate

Active Ingredients

Rabies 3 Year Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 18
Cat 1

Most Affected Breeds

Retriever - Labrador 5
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1
Boxer (German Boxer) 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Bulldog 1
Coonhound (unspecified) 1
Spaniel - Cocker English 1
Shepherd Dog - Australian 1
Beagle 1
Terrier - Fox (unspecified) 1

Most Reported Reactions

Anaphylaxis 4
Vomiting 4
Lethargy (see also Central nervous system depression in Neurological) 3
Emesis (multiple) 3
Panting 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Discomfort NOS 2
Behavioural disorder NOS 2
Diarrhoea 2
Facial swelling (see also Skin) 2
Immune mediated haemolytic anaemia 2
Not himself/herself 2

Outcome Breakdown

Ongoing
11 (57.9%)
Recovered/Normal
6 (31.6%)
Outcome Unknown
1 (5.3%)
Euthanized
1 (5.3%)

Data Summary

Metric Value
Total adverse event reports 19
Reports involving death 1
Case-fatality rate (reported events) 530.0%
Distinct species in reports 2
Distinct breeds in reports 15
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Rabies 3 Year Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 19 adverse event reports referencing Rabies 3 Year Vaccine, including 1 reports in which the animal died — a 530.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Rabies 3 Year Vaccine. Reported administration routes include Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Rabies 3 Year Vaccine reports are Dog (18 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (5), Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) (1), Boxer (German Boxer) (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Rabies 3 Year Vaccine are Anaphylaxis (4), Vomiting (4), Lethargy (see also Central nervous system depression in Neurological) (3), Emesis (multiple) (3). Of the 19 reports with a coded outcome, Ongoing is the leading category at 57.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Rabies 3 Year Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial